Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Smith

Showing results (231-240 of 255) with videos related to

Pageof 26
Sort By:
Cancer|September 1, 1990
Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancerE H Cooper, T G Armitage, M R Robinson, et al.
British Medical Journal (Clinical Research Ed.)|June 25, 1988
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)D A Tolley, T B Hargreave, P H Smith, et al.
European Urology|January 1, 1977
The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracilM R Robinson, P H Smith, M P Macaluso, et al.
Progress in Clinical and Biological Research|January 1, 1987
Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancerL Denis, F Keuppens, C Mahler, et al.
European Urology|January 1, 1990
Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU GroupL Denis, P H Smith, J L De Moura, et al.
The Journal of Urology|October 1, 1988
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinomaF M Debruyne, L Denis, G Lunglmayer, et al.
The Journal of Urology|September 1, 1986
A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of CancerP H Smith, S Suciu, M R Robinson, et al.
Progress in Clinical and Biological Research|January 1, 1989
EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological GroupM Pavone-Macaluso, F H Schröder, H J de Voogt, et al.
British Journal of Cancer|July 2, 1999
Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancerA S Protheroe, R E Banks, M Mzimba, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG)P H Smith, J A Child, J H Mulder, et al.
Pageof 26

Showing results (231-240 of 255) with videos related to

Sort By:
Pageof 26
Cancer|September 1, 1990
Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancerE H Cooper, T G Armitage, M R Robinson, et al.
British Medical Journal (Clinical Research Ed.)|June 25, 1988
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)D A Tolley, T B Hargreave, P H Smith, et al.
European Urology|January 1, 1977
The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracilM R Robinson, P H Smith, M P Macaluso, et al.
Progress in Clinical and Biological Research|January 1, 1987
Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancerL Denis, F Keuppens, C Mahler, et al.
European Urology|January 1, 1990
Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU GroupL Denis, P H Smith, J L De Moura, et al.
The Journal of Urology|October 1, 1988
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinomaF M Debruyne, L Denis, G Lunglmayer, et al.
The Journal of Urology|September 1, 1986
A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of CancerP H Smith, S Suciu, M R Robinson, et al.
Progress in Clinical and Biological Research|January 1, 1989
EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological GroupM Pavone-Macaluso, F H Schröder, H J de Voogt, et al.
British Journal of Cancer|July 2, 1999
Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancerA S Protheroe, R E Banks, M Mzimba, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG)P H Smith, J A Child, J H Mulder, et al.
Pageof 26